• -
136 Results
A woman receives a vaccine in her left arm.
How Too Much Freedom of Choice Endangers Public Health: The Effect of Nonmedical Exemptions From School-entry Vaccinations in Texas
This policy brief analyzes the impact of the increasing number of parents who opt their children out of school-entry vaccinations for nonmedical reasons in Texas and argues that the state should make obtaining nonmedical exemptions more rigorous in order to reduce the public health risks and costs associated with vaccine-preventable diseases.
Jackie Olive, Kirstin R.W. Matthews October 13, 2016
Vital Role of White House S&T Policy
The director of the White House Office of Science and Technology Policy (OSTP) plays a central role in advising the president on the impact of science and technology on domestic and global affairs, and on federal funding of scientific research. This paper provides recommendations for the next president to consider when choosing a science advisor and establishing science and technology policy priorities. The project also offers guidance to the next science advisor for developing effective policy while serving in the White House. The recommendations are based on lessons learned from past presidential science advisors as well as feedback from more than 60 reviewers, including individuals who currently serve or have served the OSTP, the President’s Council of Advisors for Science and Technology, federal agencies, Congress or congressional staff, and nongovernmental organizations as well as policy scholars.
Neal F. Lane, Kirstin R.W. Matthews, Kenneth M. Evans September 12, 2016
Pen pointing at chart
Drugs by the Numbers: The Brian C. Bennett Drug Charts
Using charts, figures and graphs of this survey data originally created by former career intelligence analyst Brian C. Bennett and updated by the Drug Policy Program, this issue brief offers an overview of drug use trends in America over the last four decades. The brief is part of a larger online project chronicling the pattern of the use and abuse of individual drugs over (in most cases) more than 40 years.
William Martin, Katharine Neill Harris August 1, 2016